GNMX
Corgi Genomics & Precision Medicine ETF
GNMX
Closed
$32.29
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
GNMX was created on 2026-05-06 by Corgi. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1.45m in AUM and 59 holdings. GNMX seeks capital appreciation through a portfolio of companies tiedto thegenomics and precision medicine value chain, from sequencing platforms and bioinformatics engines to gene editors, molecular diagnostics, targeted therapies, and clinical data platforms.
Company
Corgi
Asset class
Equity
Inception date
2026
Investment segment
Theme
ISIN
US2189468463
Website
Key stats
Open
$32.29
Volume
1.45K
AUM
$1.45M
Prev. close
$31.94
Expense ratio
0.35%
P/E
0.00
$32.28
Day’s Range
$32.29
$23.88
52W Range
$32.47
What’s in the fund
59
Total holdings
Thermo Fisher Scientific Inc
8.89%
Vertex Pharmaceuticals Inc
6.74%
Illumina Inc
3.95%
Revolution Medicines Inc Ordinary Shares
3.89%
Guardant Health Inc
3.87%
Moderna Inc
3.29%
Incyte Corp
3.15%
First American Government Obligs X
2.98%
Genmab AS ADR
2.96%
Others
60.28%
Returns
Performance
_
Difference
_
Corgi Genomics & Precision Medicine ETF
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply